Gene · 1585
Papers3,065
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,065
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aldosterone synthase inhibitors across the translational spectrum: Mechanistic foundations and emerging clinical applications. | J Intern Med | 2026 | 41491887 | PubTator, text mining | PubMed |
| Selected updates in thyroid, parathyroid, and adrenal gland pathology. | Hum Pathol | 2026 | 41490755 | PubTator, text mining | PubMed |
| Obstructive Sleep Apnea and Hypertension: Is Aldosterone Blockade the Optimal Approach to Control Blood Pressure and Improve Oxygenation? | Curr Hypertens Rep | 2026 | 41483355 | PubTator, text mining | PubMed |
| Pharmacodynamics of vicadrostat for aldosterone synthase inhibition in patients with CKD. | Eur J Endocrinol | 2026 | 41436034 | PubTator, text mining | PubMed |
| Lorundrostat for Patients With Uncontrolled Hypertension: A Systematic Review With Meta-Analysis and Trial Sequential Analysis. | Am J Hypertens | 2026 | 41428443 | PubTator, text mining | PubMed |
| FOS and JUN regulate oxidative stress and steroidogenesis in human aldosterone-producing adenomas. | Redox Biol | 2026 | 41412035 | PubTator, text mining | PubMed |
| Immunohistochemistry-guided analyses of steroidogenesis in primary bilateral macronodular adrenal hyperplasia. | J Endocrinol | 2026 | 41404845 | PubTator, text mining | PubMed |
| Pathology of adrenal tumours: recent advances. | Histopathology | 2026 | 41384706 | PubTator, text mining | PubMed |
| Efficacy and safety of lorundrostat in uncontrolled hypertension: A GRADE-assessed systematic review and meta-analysis of randomized controlled trials. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 41379320 | PubTator, text mining | PubMed |
| CYP11B2 expression patterns in primary aldosteronism: Assessment of cortisol co-secretion and the B2 ratio criteria. | Hum Pathol | 2026 | 41354161 | PubTator, text mining | PubMed |
| Single-cell transcriptomic analysis reveals metabolic reprogramming and tumor microenvironment remodeling in aldosterone-producing adenoma. | Genomics | 2026 | 41317749 | PubTator, text mining | PubMed |
| Primary Aldosteronism: Small Molecule Antagonists of Mutant KCNJ5 Potassium Channels. | Hypertension | 2026 | 41263073 | PubTator, text mining | PubMed |
| Efficacy and safety of lorundrostat in uncontrolled hypertension: a meta-analysis. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 41251750 | PubTator, text mining | PubMed |
| Weekly Journal Scan: Targeting aldosterone synthase in uncontrolled and resistant hypertension. | Eur Heart J | 2026 | 41251078 | PubTator, text mining | PubMed |
| Targeted editing of the 21-hydroxylase locus confers durable therapeutic effect in a murine model of congenital adrenal hyperplasia. | Mol Ther | 2026 | 41220178 | PubTator, text mining | PubMed |
| Insights Into Aldosterone Regulation Through Pharmacokinetic-Pharmacodynamic Modeling of an Aldosterone Synthase Inhibitor. | Clin Pharmacol Ther | 2026 | 41190731 | PubTator, text mining | PubMed |
| Persistent Renin Suppression After Unilateral Adrenalectomy for Primary Aldosteronism: Implications for Adverse Outcome? | J Clin Endocrinol Metab | 2026 | 41175007 | PubTator, text mining | PubMed |
| Peptide Deformylase Regulates Aldosterone Production Through Calbindin 1. | Hypertension | 2026 | 41104452 | PubTator, text mining | PubMed |
| False-positive results of adrenal venous sampling due to mild autonomous cortisol secretion in a patient with primary aldosteronism: a case report with review of literature. | Endocr J | 2026 | 40967826 | PubTator, text mining | PubMed |
| Mechanisms of diabetic kidney disease and established and emerging treatments. | Nat Rev Endocrinol | 2026 | 40935879 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1585/papers?page=7